Clinical studies recruiting near Naperville

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart
Phase 3 · CON-10025, Naperville, IL · Colorado Prevention Center · NCT06024746 Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
Phase 3 · Vanda Investigational Site · Vanda Pharmaceuticals · NCT06953869 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Endeavor Health · Pfizer · NCT06758401 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · Chicago Headache Center & Research Institute · Kallyope Inc. · NCT07674654 A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Sympt
Phase 4 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT07105111 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · Edward Hospital/Cancer Center · NRG Oncology · NCT05946213 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Edward Hospital/Cancer Center · NRG Oncology · NCT05174169 Zenith® Fenestrated+ Clinical Study
NA · Edward Hospital · Cook Research Incorporated · NCT04875429 A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancre
Phase 3 · Investigative Site US005 · Incyte Corporation · NCT07522073 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Edward Hospital/Cancer Center · National Cancer Institute (NCI) · NCT04269902 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Edward Hospital/Cancer Center · Canadian Cancer Trials Group · NCT06592924 Prevail Global Study
NA · Midwest Cardiovascular Institute · Medtronic Vascular · NCT06535854 E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · Edward Hospital/Cancer Center · NRG Oncology · NCT06748222 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants Wi
Phase 3 · Research Site · AstraZeneca · NCT05211895 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Edward Hospital/Cancer Center · NRG Oncology · NCT04852887 Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
Phase 2 · Bioluminux Clinical Research · Atom Therapeutics Co., Ltd · NCT07145229 Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
Phase 3 · Oak Dermatology · Regeneron Pharmaceuticals · NCT06585410 Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Phase N/A · Edward Hospital/Cancer Center · ECOG-ACRIN Cancer Research Group · NCT04239573 Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · Edward Hospital/Cancer Center · National Cancer Institute (NCI) · NCT05987241 A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Phase 3 · Edward Hospital/Cancer Center · National Cancer Institute (NCI) · NCT05675410 The CONFORM Pivotal Trial
NA · Midwest Cardiovascular Institute · Conformal Medical, Inc · NCT05147792 Left vs Left Randomized Clinical Trial
NA · CIS Clinical Research Corporation · Baylor College of Medicine · NCT05650658 A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Parti
Phase 3 · Edward-Elmhurst Healthcare, Edward Hospital-Edward Cancer Ce · Merck Sharp & Dohme LLC · NCT06312137 Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Diffe
Phase 3 · Edward Hospital/Cancer Center · National Cancer Institute (NCI) · NCT06422806 Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Phase 3 · Edward Hospital/Cancer Center · National Cancer Institute (NCI) · NCT06337318 Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Hear
NA · Midwest Cardiovascular Institute · Boston Scientific Corporation · NCT07069738 A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resist
Phase 3 · Edward-Elmhurst Healthcare, Edward Hospital-Edward Cancer Ce · Merck Sharp & Dohme LLC · NCT06136650 Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT05855200 A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
NA · Edward Hospital/Cancer Center · NRG Oncology · NCT04251052

Look up another city

Look up another condition